Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).
Conte PF, Baldini E, Gardin G, Pronzato P, Amadori D, Carnino F, Monzeglio C, Gentilini P, Gallotti P, DeMicheli R, Venturini M, Rubagotti A, Rosso R. Conte PF, et al. Among authors: amadori d. Ann Oncol. 1996 Jul;7(5):487-90. doi: 10.1093/oxfordjournals.annonc.a010637. Ann Oncol. 1996. PMID: 8839903 Free article. Clinical Trial.
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Baldini E, Gardin G, Naso C, Pronzato P, Rosso R, Rubagotti A, Monzeglio C, Brema F, Pastorino G, Amadori D, et al. Baldini E, et al. Among authors: amadori d. Ann N Y Acad Sci. 1993 Nov 30;698:418-22. doi: 10.1111/j.1749-6632.1993.tb17235.x. Ann N Y Acad Sci. 1993. PMID: 8279781 Clinical Trial. No abstract available.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F, Rubagotti A, Puntoni M, Guglielmini P, Amoroso D, Fini A, Paladini G, Mesiti M, Romeo D, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P. Boccardo F, et al. Among authors: amadori d. J Clin Oncol. 2005 Aug 1;23(22):5138-47. doi: 10.1200/JCO.2005.04.120. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009955 Clinical Trial.
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.
Boccardo F, Amadori D, Guglielmini P, Sismondi P, Farris A, Agostara B, Gambi A, Catalano G, Faedi M, Rubagotti A. Boccardo F, et al. Among authors: amadori d. Oncology. 2010;78(3-4):274-81. doi: 10.1159/000315735. Epub 2010 Jun 8. Oncology. 2010. PMID: 20530973 Clinical Trial.
518 results